Compare BIO & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | ADC |
|---|---|---|
| Founded | 1952 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.0B |
| IPO Year | N/A | 1994 |
| Metric | BIO | ADC |
|---|---|---|
| Price | $300.28 | $72.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $358.50 | $80.75 |
| AVG Volume (30 Days) | 170.4K | ★ 1.2M |
| Earning Date | 10-29-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | ★ $2,557,500,000.00 | $688,643,000.00 |
| Revenue This Year | $1.77 | $15.94 |
| Revenue Next Year | $2.30 | $11.30 |
| P/E Ratio | ★ N/A | $42.11 |
| Revenue Growth | N/A | ★ 14.67 |
| 52 Week Low | $211.43 | $67.58 |
| 52 Week High | $373.69 | $79.65 |
| Indicator | BIO | ADC |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 45.35 |
| Support Level | $298.02 | $70.72 |
| Resistance Level | $307.78 | $72.81 |
| Average True Range (ATR) | 8.35 | 1.06 |
| MACD | -2.13 | -0.10 |
| Stochastic Oscillator | 16.30 | 37.04 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.